Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)

SHA:688393 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,823	1,620	2,336	2,053	2,844	3,452
Market Cap Growth	66.50%	-30.68%	13.78%	-27.80%	-17.60%	-
Enterprise Value	2,546	1,498	2,207	1,734	2,081	2,623
Last Close Price	30.17	17.25	24.66	21.60	29.54	35.60
PE Ratio	-	76.07	58.33	48.10	35.65	40.73
PS Ratio	7.61	3.44	4.70	4.05	6.48	9.19
PB Ratio	2.35	1.32	1.89	1.68	2.35	2.96
P/TBV Ratio	2.37	1.32	1.90	1.72	2.43	2.99
P/FCF Ratio	125.95	-	-	-	-	119.12
P/OCF Ratio	73.28	457.11	136.46	211.34	47.71	37.75
EV/Sales Ratio	6.86	3.18	4.44	3.42	4.74	6.99
EV/EBITDA Ratio	-	44.48	48.25	32.22	27.63	29.69
EV/EBIT Ratio	-	-	292.63	80.72	35.40	33.68
EV/FCF Ratio	113.58	-	-	-	-	90.53
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.01	-
Debt / EBITDA Ratio	5.87	0.30	0.58	0.43	0.16	-
Asset Turnover	0.28	0.34	0.36	0.37	0.33	0.41
Inventory Turnover	1.56	2.00	2.35	2.88	3.01	3.34
Quick Ratio	6.39	4.71	3.35	4.46	7.99	11.82
Current Ratio	9.05	8.19	5.14	5.21	8.51	12.16
Return on Equity (ROE)	-1.64%	1.21%	1.71%	2.41%	6.33%	10.37%
Return on Assets (ROA)	-1.73%	-0.21%	0.34%	0.97%	2.77%	5.32%
Return on Invested Capital (ROIC)	-3.72%	-0.41%	0.71%	2.74%	10.85%	21.89%
Return on Capital Employed (ROCE)	-3.00%	-0.40%	0.60%	1.70%	4.70%	6.50%
Earnings Yield	-0.68%	1.31%	1.71%	2.08%	2.80%	2.46%
FCF Yield	0.79%	-1.24%	-0.88%	-3.04%	-2.94%	0.84%
Dividend Yield	0.33%	0.58%	0.61%	0.65%	0.91%	0.79%
Payout Ratio	-	68.14%	33.62%	62.34%	33.00%	-
Buyback Yield / Dilution	6.37%	2.94%	-0.53%	-1.09%	-20.71%	-11.39%
Total Shareholder Return	6.70%	3.52%	0.08%	-0.44%	-19.80%	-10.60%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.